Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/25197
Tipo
ArtículoDerechos de autor
Acceso restringido
Fecha del embargo
2030-01-01
Colecciones
- IOC - Artigos de Periódicos [12596]
Metadatos
Mostrar el registro completo del ítem
A SUMMARY OF THE 25TH INTERNATIONAL PAPILLOMAVIRUS CONFERENCE 2009: VACCINES, SCREENING, EPIDEMIOLOGY AND THERAPEUTICS
Vacina
Conferência Internacional sobre HPV
Epidemiologia
Revisão
Triagem
Afiliación
Fundação Oswaldo Cruz. Laboratório Interdisciplinar de Pesquisas Médicas. Rio de Janeiro, RJ, Brasil
Ohio State University Medical Center. Gerard Nuovo – Comprehensive Cancer Center. Columbus, OH, USA.
Lund University Malmö, Sweden.
Ohio State University Medical Center. Gerard Nuovo – Comprehensive Cancer Center. Columbus, OH, USA.
Lund University Malmö, Sweden.
Resumen en ingles
The 25th International Papillomavirus Conference was held in Malmo, Sweden, on May 8-14, 2009. The conference encompassed all areas of papillomavirus (PV) research, from clinical vaccinology to molecular biology. This review highlights some of the 237 presentations and 887 abstracts which were presented and summarizes sessions on prophylactic vaccines, screening, epidemiology and therapeutics. Important advances included identification of variants in four genes associated with HPV persistence, new HPV detection are likely new infections and not latency reactivation, and development of effective DNA vaccines that targets E6/E7 genes of HPV11. Also, many studies from different countries demonstrated that HPV vaccination provided sustained protection and substantial reduction of disease burden in both women and men, and in HIV-infected neonates. All the references cited are from the abstract book of the IPV Conference. See http://www.hpv2009.org/.
Palabras clave en portugues
HPVVacina
Conferência Internacional sobre HPV
Epidemiologia
Revisão
Triagem
Compartir